These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 26387449)

  • 1. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
    Wang Y; Li S; Li C
    Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranal Expression of Calreticulin Induced by Unfolded Protein Response in Melanocytes: A Mechanism Underlying Oxidative Stress-Induced Autoimmunity in Vitiligo.
    Song P; Zhang W; Guo S; Wang G; Gao T; Li C; Liu L
    J Invest Dermatol; 2024 Jul; 144(7):1622-1632.e5. PubMed ID: 38246583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research progress of vitiligo repigmentation: from oxidative stress to autoimmunity.
    Yu T; Wu Y; Lu Z
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):147-151. PubMed ID: 38678613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of immune hyporesponsiveness to melanosomal proteins by DHICA-mediated antioxidation: Possible implications for autoimmune vitiligo.
    Liu XM; Zhou Q; Xu SZ; Wakamatsu K; Lei TC
    Free Radic Biol Med; 2011 May; 50(9):1177-85. PubMed ID: 21256957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune etiology of generalized vitiligo.
    Le Poole IC; Luiten RM
    Curr Dir Autoimmun; 2008; 10():227-43. PubMed ID: 18460889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity.
    Lin X; Tian H; Xianmin M
    Med Hypotheses; 2011 Mar; 76(3):339-42. PubMed ID: 21075543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
    Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
    Front Immunol; 2020; 11():624566. PubMed ID: 33613564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.
    Toosi S; Orlow SJ; Manga P
    J Invest Dermatol; 2012 Nov; 132(11):2601-9. PubMed ID: 22696056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative Stress-Induced Chemokine Production Mediates CD8(+) T Cell Skin Trafficking in Vitiligo.
    Li S; Zhu G; Yang Y; Guo S; Dai W; Wang G; Gao T; Li C
    J Investig Dermatol Symp Proc; 2015 Jul; 17(1):32-3. PubMed ID: 26067315
    [No Abstract]   [Full Text] [Related]  

  • 12. Bilobalide protection of normal human melanocytes from hydrogen peroxide-induced oxidative damage via promotion of antioxidase expression and inhibition of endoplasmic reticulum stress.
    Lu L; Wang S; Fu L; Liu D; Zhu Y; Xu A
    Clin Exp Dermatol; 2016 Jan; 41(1):64-73. PubMed ID: 26178968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current remedies for vitiligo.
    Abu Tahir M; Pramod K; Ansari SH; Ali J
    Autoimmun Rev; 2010 May; 9(7):516-20. PubMed ID: 20149899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected?
    Namazi MR
    Pigment Cell Res; 2007 Oct; 20(5):360-3. PubMed ID: 17850509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo Pathogenesis and Emerging Treatments.
    Rashighi M; Harris JE
    Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes.
    Zhang Y; Liu L; Jin L; Yi X; Dang E; Yang Y; Li C; Gao T
    J Invest Dermatol; 2014 Jan; 134(1):183-191. PubMed ID: 23771121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library.
    Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
    J Invest Dermatol; 2010 Jan; 130(1):230-40. PubMed ID: 19587696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and immune system in vitiligo and thyroid diseases.
    Colucci R; Dragoni F; Moretti S
    Oxid Med Cell Longev; 2015; 2015():631927. PubMed ID: 25838868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.